The nuclear option for insulinomas

The Lancet Diabetes and Endocrinology

Volumn 1, Issue 2, 2013, Pages 82-84

  Grossman, Ashley ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; EXENDIN 4; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; PENTETIC ACID; SOMATOSTATIN; INDIUM; PEPTIDE; VENOM;

BENIGN TUMOR; CANCER SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ENDOSCOPIC ECHOGRAPHY; FALSE POSITIVE RESULT; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINOMA; LETTER; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RARE DISEASE; TUMOR LOCALIZATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC USE; FEMALE; MALE; PANCREAS TUMOR; PROCEDURES; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FEMALE; HUMANS; INDIUM RADIOISOTOPES; INSULINOMA; MALE; PANCREATIC NEOPLASMS; PENTETIC ACID; PEPTIDES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENOMS;

EID: 84884502849     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70060-3     Document Type: Letter

References (8)

1. Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2009, 94:709-728.
2. Coelho C, Druce MR, Grossman AB Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia. Nat Rev Endocrinol 2009, 5:628-631.
3. Druce MR, Muthuppalaniappan VM, O'Leary B, et al. Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation. Eur J Endocrinol 2010, 162:971-978.
4. Morganstein DL, Lewis DH, Jackson J, et al. The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinoma. Eur Radiol 2009, 19:2467-2473.
5. Guettier JM, Kam A, Chang R, et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J Clinical Endocrinol Metab 2009, 94:1074-1080.
6. Christ E, Wild D, Ederer S, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013, published online July 25. http://dx.doi.org/10.1016/S2213-8587(13)70049-4.
7. Christ E, Wild D, Forrer F, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab 2009, 94:4398-4405.
8. Wild D, Christ E, Caplin ME, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011, 52:1073-1078.